Search

Author/Creator Winer, Eric P

3. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial. Issue 3 (March 2023)

Authors:
Tolaney, Sara M; Tarantino, Paolo; Graham, Noah; Tayob, Nabihah; Parè, Laia; Villacampa, Guillermo; Dang, Chau T; Yardley, Denise A; Moy, Beverly; Marcom, P Kelly; Albain, Kathy S; Rugo, Hope S; Ellis, Matthew J; Shapira, Iuliana; Wolff, Antonio C; Carey, Lisa A; Barroso-Sousa, Romualdo; Villagra...
Journal:
Lancet oncology
Issue:
Volume 24:Issue 3(2023)
Page Start:
273
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies. (15th November 2018)

Authors:
Kensler, Kevin H; Poole, Elizabeth M; Heng, Yujing J; Collins, Laura C; Glass, Benjamin; Beck, Andrew H; Hazra, Aditi; Rosner, Bernard A; Eliassen, A Heather; Hankinson, Susan E; Winer, Eric P; Brown, Myles; Tamimi, Rulla M
Journal:
Journal of the National Cancer Institute
Issue:
Volume 111:Number 7(2019)
Page Start:
700
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study. (1st February 2021)

Authors:
Emens, Leisha A; Molinero, Luciana; Loi, Sherene; Rugo, Hope S; Schneeweiss, Andreas; Diéras, Véronique; Iwata, Hiroji; Barrios, Carlos H; Nechaeva, Marina; Nguyen-Duc, Anh; Chui, Stephen Y; Husain, Amreen; Winer, Eric P; Adams, Sylvia; Schmid, Peter
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 8(2021)
Page Start:
1005
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2020)

Authors:
Schmid, Peter; Rugo, Hope S; Adams, Sylvia; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Diéras, Véronique; Henschel, Volkmar; Molinero, Luciana; Chui, Stephen Y; Maiya, Vidya; Husain, Amreen; Winer, Eric P; Loi, Sherene; Emens, Leisha A
Journal:
Lancet oncology
Issue:
Volume 21:Issue 1(2020)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Expanding Criteria for Prognostic Stage IA in Hormone Receptor–Positive Breast Cancer. (19th May 2021)

Authors:
Kantor, Olga; King, Tari A; Shak, Steven; Russell, Christy A; Giuliano, Armando E; Hortobagyi, Gabriel N; Burstein, Harold J; Winer, Eric P; Dey, Tanujit; Sparano, Joseph A; Mittendorf, Elizabeth A
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 12(2021)
Page Start:
1744
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. High performance teamwork training and systems redesign in outpatient oncology. Issue 5 (24th January 2013)

Authors:
Bunnell, Craig A; Gross, Anne H; Weingart, Saul N; Kalfin, Michael Jason; Partridge, Ann; Lane, Sharon; Burstein, Harold J; Fine, Barbara; Hilton, Nancy A; Sullivan, Clare; Hagemeister, Erin E; Kelly, Anne E; Colicchio, Lynn; Szabatura, Audrea H; Winer, Eric P; Salisbury, Mary; Mann, Susan
Journal:
BMJ quality & safety
Issue:
Volume 22:Issue 5(2013)
Page Start:
405
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study. Issue 2 (February 2021)

Authors:
Mayer, Erica L; Dueck, Amylou C; Martin, Miguel; Rubovszky, Gabor; Burstein, Harold J; Bellet-Ezquerra, Meritxell; Miller, Kathy D; Zdenkowski, Nicholas; Winer, Eric P; Pfeiler, Georg; Goetz, Matthew; Ruiz-Borrego, Manuel; Anderson, Daniel; Nowecki, Zbigniew; Loibl, Sibylle; Moulder, Stacy; Ring,...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 2(2021)
Page Start:
212
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer. (7th June 2021)

Authors:
Rugo, Hope S; Loi, Sherene; Adams, Sylvia; Schmid, Peter; Schneeweiss, Andreas; Barrios, Carlos H; Iwata, Hiroji; Diéras, Véronique; Winer, Eric P; Kockx, Mark M; Peeters, Dieter; Chui, Stephen Y; Lin, Jennifer C; Nguyen-Duc, Anh; Viale, Giuseppe; Molinero, Luciana; Emens, Leisha A
Journal:
Journal of the National Cancer Institute
Issue:
Volume 113:Number 12(2021)
Page Start:
1733
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗